Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

The relation between peptide hormones and sex hormone in patients with multiple sclerosis.
Markers of oxidative stress in plasma and saliva in patients with multiple sclerosis.
Neuroscience. To learn is to myelinate.
Altered lipid levels provide evidence for myelin dysfunction in multiple system atrophy.
Framework for Assessment of the Usability of Lower-Extremity Robotic Exoskeletal Orthoses.
Disseminated cryptococcosis in a patient with multiple sclerosis treated with fingolimod.
CD14 is a key organizer of microglial responses to CNS infection and injury.
Fingolimod targeting protein phosphatase 2A differently affects IL-33 induced IL-2 and IFN-γ production in CD8(+) lymphocytes.
Treatment of Neuropathic Pain and Functional Limitations Associated With Multiple Sclerosis Using an MRI-Compatible Spinal Cord Stimulator: A Case Report With Two Year Follow-Up and Literature Review.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Oligodendrocyte-Specific Activation of PERK Signaling Protects Mice against Experimental Autoimmune Encephalomyelitis.
The first 10 years with multiple sclerosis: The longitudinal course of daily functioning.
The discovery of natalizumab, a potent therapeutic for multiple sclerosis.
The radiologically isolated syndrome.
Epidemiology of amyotrophic lateral sclerosis in Isfahan, Iran.
Acute transverse myelitis following Japanese encephalitis viral infection: an uncommon complication of a common disease.
Multiple sclerosis: clinical features and MRI findings in Northern China.
Genetic targeting of microglia.
Copaiba Oil Suppresses Inflammatory Cytokines in Splenocytes of C57Bl/6 Mice Induced with Experimental Autoimmune Encephalomyelitis (EAE).
Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.
Chronic oligodendrogenesis and remyelination after spinal cord injury in mice and rats.
The pathogenic role of the inflammasome in neurodegenerative diseases.
Bupropion-Related Visual Hallucinations in a Veteran With Posttraumatic Stress Disorder and Multiple Sclerosis.
Efficacy and safety of secukinumab in patients with rheumatoid arthritis: a phase II, dose-finding, double-blind, randomised, placebo controlled study.
New EMA Advice to Reduce PML Risk With Natalizumab (Tysabri) in MS

Pages